CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...
Phase 2
San Francisco, California, United States
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...
Phase 3
Palo Alto, California, United States and 30 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Walnut Creek, Colorado, United States of America and 98 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Francisco, California, United States and 221 other locations
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.Thi-...
Phase 3
Walnut Creek, Colorado, United States of America and 18 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 3
Oakland, California, United States and 100 other locations
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...
Phase 3
Walnut Creek, Colorado, United States of America and 199 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Walnut Creek, California, United States and 94 other locations
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...
Palo Alto, California, United States and 2 other locations
This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...
Phase 2
San Francisco, California, United States
Clinical trials
Research sites
Resources
Legal